Source: The Lancet. Unidade: FMRP
Subjects: CARDIOLOGIA, DOENÇAS CARDIOVASCULARES (EPIDEMIOLOGIA)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MARIN-NETO, José Antônio. Effects of recombinant hirudin (lepirudin) compared with heparin on death, myocardial infarction, refractory angina, and revascularisation procedures in patients with acute myocardial ischaemia without ST elevation: a^randomised trial. The Lancet, v. 353, n. 6, p. 429-438, 1999Tradução . . Acesso em: 13 nov. 2024.APA
Marin-Neto, J. A. (1999). Effects of recombinant hirudin (lepirudin) compared with heparin on death, myocardial infarction, refractory angina, and revascularisation procedures in patients with acute myocardial ischaemia without ST elevation: a^randomised trial. The Lancet, 353( 6), 429-438.NLM
Marin-Neto JA. Effects of recombinant hirudin (lepirudin) compared with heparin on death, myocardial infarction, refractory angina, and revascularisation procedures in patients with acute myocardial ischaemia without ST elevation: a^randomised trial. The Lancet. 1999 ; 353( 6): 429-438.[citado 2024 nov. 13 ]Vancouver
Marin-Neto JA. Effects of recombinant hirudin (lepirudin) compared with heparin on death, myocardial infarction, refractory angina, and revascularisation procedures in patients with acute myocardial ischaemia without ST elevation: a^randomised trial. The Lancet. 1999 ; 353( 6): 429-438.[citado 2024 nov. 13 ]
